MENU
MESO
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Mesoblast (MESO) Ownership - Who owns Mesoblast?
Mesoblast Ltd is a biotechnology company... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
Level 38, 55 Collins Street
Phone
+61 396396036
Employees
83
Web
https://www.mesoblast.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.66B
P/E Ratio
N/A
Total Cash
37.66M
Projected Growth
N/A
Total Debt
126.11M
Revenue
5.67M
Risk (Beta)
2.15
Dividend Yield
N/A
Total Cash/Share
0.29
Total Debt/Equity
N/A
Revenue/Share
0.14 USD as % of share price
Fundamentals
MESO
Capitalization
1.66B
P/E Ratio
N/A
Risk (Beta)
2.15
Dividend Yield
N/A
Total Cash
37.7M
Total Cash/Share
0.29
Total Debt
126M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.14%
Revenue
5.67M
ROE
N/A
Book Value
461M
P/B Ratio
2.90
Cash Flow
N/A
Earnings
-89.15
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
1.32B
Current Ratio
0.96
Current Revenue Per Employee
25771.08
Dividends Per Share - Security
N/A
EBITDA
-77.78M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-15.62
Shares Held By Institutions
56.4M
Shares Outstanding - Current
128M
Total Liabilities
192M
Total Volume MTD
N/A
Value
-1
Gain YTD
-31.717
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. MESO showed earnings on August 28, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information
General Information
a company, which engages in the development and commercialization of biological products
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
Level 38, 55 Collins Street
Phone
+61 396396036
Employees
83
Web
https://www.mesoblast.com